ORIGINAL ARTICLE
Knockdown of TRIM66 in MDA-MB-468 triple negative breast cancer cell line suppresses proliferation and promotes apoptosis through EGFR signaling
,
 
,
 
 
 
More details
Hide details
1
Shanxi Provincial Tumor Hospital and Affiliated Tumor Hospital of Shanxi Medical University, P.R. China
 
 
Submission date: 2021-01-26
 
 
Final revision date: 2021-06-07
 
 
Acceptance date: 2021-06-11
 
 
Publication date: 2021-09-30
 
 
Pol J Pathol 2021;72(2):160-166
 
KEYWORDS
TOPICS
ABSTRACT
Triple negative breast cancer (TNBC) is one of the most common malignant tumors in women and the tripartite motif 66 (TRIM66) is closely associated with the behaviors of wide variety of cancer. Thus, in this study, we aimed to explore the effect of TRIM66 in MDA-MB-468 TNBC cell line. Western blot and RT-PCR assays were used to detect the expression level of TRIM66 in human normal mammary cells and human breast cancer cell lines. We silenced its expression in MDA-MB-468 cells by transient siRNA transfection to ascertain the function of TRIM66 in MDA-MB-468 cells. CCK8 and clonogenicity assays were used to evaluate the ability of cell proliferation. Wound healing and Transwell were used to detect cell invasion and migration. TUNEL was applied to detect the apoptosis level. Western blotting was used to detect the expression of related proteins. TRIM66 was observed markedly elevated in breast cancer cell line. Knockdown of TRIM66 inhibited the expression of EGFR, P-Jak2, P-STAT3, JAK2, and STAT3 in MDA-MB-468 cells through regulating the epidermal growth factor receptor (EGFR) signaling. Knockdown of TRIM66 suppresses proliferation, invasion and migration of MDA-MB-468 cell line and promotes apoptosis in these cells through EGFR signaling.
REFERENCES (30)
1.
Chen Z, Xu L, Shi W, et al. Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990-2017. Breast Cancer Res Treat 2020; 180: 481-490.
 
2.
Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010; 363: 1938-1948.
 
3.
Gonzalez TL, Hancock M, Sun S, et al. Targeted degradation of activating estrogen receptor alpha ligand-binding domain mutations in human breast cancer. Breast Cancer Res Treat 2020; 180: 611-622.
 
4.
Xiao T, Li W, Wang X, et al. Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy. Proc Natl Acad Sci U S A 2018; 115: 7869-7878.
 
5.
Li YW, Xu J, Zhu GY, et al. Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity. Cell Death Discov 2018; 4: 105.
 
6.
Dai HY, Ma Y, Da Z, Hou XM. Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer. Pathol Res Pract 2018; 214: 1130-1135.
 
7.
Wang M, Chao C, Luo G, et al. Prognostic significance of TRIM59 for cancer patient survival: A systematic review and meta-analysis. Medicine (Baltimore) 2019; 98: e18024.
 
8.
Shi G, Lv C, Yang Z, et al. TRIM31 promotes proliferation, invasion and migration of glioma cells through Akt signaling pathway. Neoplasma 2019; 66: 727-735.
 
9.
Liang C, Dong H, Miao C, et al. TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis. Oncotarget 2018; 9: 12323-12332.
 
10.
Pan Y, Zhang R, Chen H, et al. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193. Med Sci Monit 2019; 25: 98-106.
 
11.
Chen Y, Guo Y, Yang H, et al. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome. Oncotarget 2015; 6: 23708-23719.
 
12.
Ma X, Li D, Gao Y, Liu C: miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66. Technol Cancer Res Treat 2019; 18: 1533033819870209.
 
13.
Cao H, Gao R, Chen L, Feng Y. TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway. FEBS Open Bio 2020; 10: 515-524.
 
14.
He T, Cui J, Wu Y, et al. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway. Life Sci 2019; 235: 116799.
 
15.
Simon N, Antignani A, Sarnovsky R, et al. Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer. J Natl Cancer Inst 1082016.
 
16.
Reddy D, Ghosh P, Kumavath R. Strophanthidin Attenuates MAPK, PI3K/AKT/mTOR, and Wnt/beta-Catenin Signaling Pathways in Human Cancers. Front Oncol 2019; 9: 1469.
 
17.
Guerra F, Quintana S, Giustina S, et al. Investigation of EGFR/pi3k/Akt signaling pathway in seminomas. Biotech Histochem 2020; 1-13.
 
18.
Reddy TP, Rosato RR, Li X, et al. A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations. Breast Cancer Res 2020; 22: 121.
 
19.
Domagala P, Huzarski T, Lubinski J, et al. Immunophenotypic predictive profiling of BRCA1-associated breast cancer. Virchows Arch 2011; 458: 55-64.
 
20.
Jaworska AM, Wlodarczyk NA, Mackiewicz A, et al. The role of TRIM family proteins in the regulation of cancer stem cell self-renewal. Stem Cells 2020; 38: 165-173.
 
21.
Zhan W, Zhang S. TRIM proteins in lung cancer: Mechanisms, biomarkers and therapeutic targets. Life Sci 2021; 118985.
 
22.
Cambiaghi V, Giuliani V, Lombardi S, et al.TRIM proteins in cancer. Adv Exp Med Biol 2012; 770: 77-91.
 
23.
Chambon M, Orsetti B, Berthe ML, et al. Prognostic significance of TRIM24/TIF-1alpha gene expression in breast cancer. Am J Pathol 2011; 178: 1461-1469.
 
24.
Zhang HG, Pan YW, Feng J, et al. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway. Eur Rev Med Pharmacol Sci 2019; 23: 2003-2012.
 
25.
Jiang Q, Zhou C, Bi Z, et al. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells. J Ocul Pharmacol Ther 2006; 22: 93-102.
 
26.
Price JT, Tiganis T, Agarwal A, et al. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3’-kinase and phospholipase C-dependent mechanism. Cancer Res 1999; 59: 5475-5478.
 
27.
Wang J, Wan W, Sun R, et al. Reduction of Akt2 expression inhibits chemotaxis signal transduction in human breast cancer cells. Cell Signal 2008; 20: 1025-1034.
 
28.
Franke TF. Intracellular signaling by Akt: bound to be specific. Sci Signal 2008; 1: pe29.
 
29.
Solberg NT, Waaler J, Lund K, et al. TANKYRASE Inhibition Enhances the Antiproliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting beta-CATENIN and AKT Signaling in Colorectal Cancer. Mol Cancer Res 2018; 16: 543-553.
 
30.
Zhang L, Wang F, Jiang Y, et al.Migration of retinal pigment epithelial cells is EGFR/PI3K/AKT dependent. Front Biosci (Schol Ed) 2013; 5: 661-671.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top